Cargando…
GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670835/ https://www.ncbi.nlm.nih.gov/pubmed/33203839 http://dx.doi.org/10.1038/s41392-020-00391-5 |
| _version_ | 1783610818814803968 |
|---|---|
| author | Hong, Kyung Soo Ahn, June Hong Jang, Jong Geol Lee, Jong Ho Kim, Hong Nam Kim, Dongha Lee, Wonhwa |
| author_facet | Hong, Kyung Soo Ahn, June Hong Jang, Jong Geol Lee, Jong Ho Kim, Hong Nam Kim, Dongha Lee, Wonhwa |
| author_sort | Hong, Kyung Soo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7670835 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76708352020-11-18 GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro Hong, Kyung Soo Ahn, June Hong Jang, Jong Geol Lee, Jong Ho Kim, Hong Nam Kim, Dongha Lee, Wonhwa Signal Transduct Target Ther Letter Nature Publishing Group UK 2020-11-17 /pmc/articles/PMC7670835/ /pubmed/33203839 http://dx.doi.org/10.1038/s41392-020-00391-5 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter Hong, Kyung Soo Ahn, June Hong Jang, Jong Geol Lee, Jong Ho Kim, Hong Nam Kim, Dongha Lee, Wonhwa GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro |
| title | GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro |
| title_full | GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro |
| title_fullStr | GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro |
| title_full_unstemmed | GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro |
| title_short | GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro |
| title_sort | gsk-lsd1, an lsd1 inhibitor, quashes sars-cov-2-triggered cytokine release syndrome in-vitro |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670835/ https://www.ncbi.nlm.nih.gov/pubmed/33203839 http://dx.doi.org/10.1038/s41392-020-00391-5 |
| work_keys_str_mv | AT hongkyungsoo gsklsd1anlsd1inhibitorquashessarscov2triggeredcytokinereleasesyndromeinvitro AT ahnjunehong gsklsd1anlsd1inhibitorquashessarscov2triggeredcytokinereleasesyndromeinvitro AT jangjonggeol gsklsd1anlsd1inhibitorquashessarscov2triggeredcytokinereleasesyndromeinvitro AT leejongho gsklsd1anlsd1inhibitorquashessarscov2triggeredcytokinereleasesyndromeinvitro AT kimhongnam gsklsd1anlsd1inhibitorquashessarscov2triggeredcytokinereleasesyndromeinvitro AT kimdongha gsklsd1anlsd1inhibitorquashessarscov2triggeredcytokinereleasesyndromeinvitro AT leewonhwa gsklsd1anlsd1inhibitorquashessarscov2triggeredcytokinereleasesyndromeinvitro |